Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation.

about

Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation.

Item

http://www.wikidata.org/entity/Q48597130

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@en

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@nl

type

Item

label

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@en

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@nl

prefLabel

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@en

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@nl

P1476

Capsaicin exerts synergistic a ...... cells through AMPK activation.

@en

P2093

Alicia Bort

http://www.w3.org/2001/XMLSchema#string

Elena Spínola

http://www.w3.org/2001/XMLSchema#string

Nieves Rodríguez-Henche

http://www.w3.org/2001/XMLSchema#string

P2860

New advances in hepatocellular carcinoma

AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function

Global cancer statistics, 2012

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Drug combination studies and their synergy quantification using the Chou-Talalay method

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.

PI3K/Akt signalling pathway and cancer.

Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment

P304

87684-87698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.21196

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Inés Díaz-Laviada

P577

2017-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29152112

http://www.w3.org/2001/XMLSchema#string

P932

5675664

http://www.w3.org/2001/XMLSchema#string